GSK Buys Asthma-Focused Aiolos

GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an additional $400 million, the latest in a string of pharmaceutical majors buying fast-growing biotechs to restock their pipelines. The British pharmaceutical giant said…#gsk #aiolosbio
Source: Reuters: Health - Category: Consumer Health News Source Type: news